

Accelerate Diagnostics is an in vitro diagnostics company providing solutions to drug resistant organisms and hospital acquired infections. Among its major competitors, Accelerate Diagnostics is ranked in 7th place for NPS while T2 Biosystems is 1st, and BioFire Diagnostics is 2nd.Their current market cap is $77.23M